Wuhan General Group

Wuhan General Group

M2Bio Sciences, a company that develops innovative healthcare solutions through cannabis and mushroom-based sciences, with focus on psilocybin and cannabinoids, targeting drug discovery and treatment sales in anxiety, depression, ADHD.

Launch date
Employees
Market cap
$5.5k
Enterprise valuation
$6k (Public information from Sep 2024)
Reno Nevada (HQ)
  • Edit
DateInvestorsAmountRound
N/A

N/A

IPO

$450k

Post IPO Equity
Total Funding-

Recent News about Wuhan General Group

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.

Investments by Wuhan General Group

Edit
JDAX
ACQUISITION by Wuhan General Group Jun 2023